Newsletter

Extracellular Vesicles (EVs) are quickly emerging as game-changers in medical science. From refining drug delivery systems to pioneering cancer immunotherapy and regenerative medicine, EV research is setting the stage for next-generation therapies. As we head toward ISEV 2025, here’s a quick look at the most exciting research trends.

As the International Society of Extracellular Vesicles (ISEV) Annual Meeting approaches, it’s the perfect time to reflect on the rapid growth and innovation in the extracellular vesicle (EV) market. With a projected compound annual growth rate (CAGR) of 18.5%, the global EV Diagnostics & Therapeutics market is expected to reach $3.28 billion by 2030...

Discover innovative EV engineering strategies with JOTBODY at ISEV 2025. Visit us at Booth B26 in Vienna, Austria, from April 24–27, 2025, and explore our innovative clinical solutions.